Following the introduction of HPV cervical screening in March 2020, and in line with best practice guidelines, the CervicalCheck Clinical Advisory Group and Senior Management Team has approved changes to Programme eligibility and recall intervals for certain screening categories. Changes to a new screening programme are very normal as we incorporate feedback from stakeholders in relation to the new algorithms or as new research is published.
The following are the changes approved by the programme:
- Women who are on renal dialysis or pre/ post-transplant are now recommended to attend for annual screening.
- All women (including those on renal transplant or pre/ post- transplant along with HIV positive and DES exposed women) will exit the screening programme at age 65.
- Women over age 65 with no requirement for screening are no longer eligible for a test.
- Women who have completed their required number of increased surveillance tests post colposcopy require one screen at a three year interval before moving to five yearly screening.
See here the new revisions of the HPV primary screening eligibility framework.